glp-1/gip/glucagon triple agonist retatrutide glp-1 gip glucagon phase 3 2025 Dual and Triple Gut Peptide Agonists Retatrutide 40mg | Triple GIP/GLP-1/Glucagon
Description
53 Another GIP/GLP-1/GCG triple RA, LY3437943, has also undergone Phase I trials
Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia
10.1016/j.neubiorev.2003.11.010 39 LautarS
If you're denied coverage for a specific drug, that may be a coverage redetermination or appeal
